Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$185.01 - $212.05 $6.68 Million - $7.66 Million
-36,100 Reduced 97.57%
900 $170,000
Q1 2023

May 12, 2023

BUY
$182.66 - $235.53 $6.43 Million - $8.29 Million
35,200 Added 1955.56%
37,000 $7.41 Million
Q3 2022

Nov 14, 2022

SELL
$138.54 - $232.0 $31 Million - $52 Million
-224,000 Reduced 99.2%
1,800 $360,000
Q2 2022

Aug 12, 2022

BUY
$120.42 - $169.29 $27 Million - $37.9 Million
224,000 Added 12444.44%
225,800 $32.9 Million
Q1 2022

May 16, 2022

SELL
$127.18 - $173.91 $4.83 Million - $6.61 Million
-38,000 Reduced 95.48%
1,800 $294,000
Q2 2021

Sep 13, 2021

BUY
$128.63 - $176.89 $5.12 Million - $7.04 Million
39,800 New
39,800 $6.75 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.